Navigation Links
CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
Date:8/28/2007

more information, please refer to http://www.topotarget.com .

Safe Harbor

Statements in this press release regarding management's future expectations, beliefs, intentions, goals, strategies, plans or prospects, including statements relating to the expected benefits of belinostat, the use of belinostat in the treatment of AML and other diseases, and the conduct, enrollment, and data relating to CuraGen's Phase I/II clinical trial for belinostat may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by terminology such as "anticipate," "believe," "could," "could increase the likelihood," "estimate," "expect," "intend," "is planned," "may," "should," "will," "will enable," "would be expected," "look forward," "may provide," "would" or similar terms, variations of such terms or the negative of those terms. Such forward-looking statements involve known and unknown risks, uncertainties and other factors including the risk that any one or more of CuraGen's drug development programs will not proceed as planned for technical, scientific or commercial reasons or due to patient enrollment issues or based on new information from nonclinical or clinical studies or from other sources, the success of competing products and technologies, CuraGen's stage of development as a biopharmaceutical company, government regulation and healthcare reform, technological uncertainty and product development risks, product liability exposure, uncertainty of additional funding, CuraGen's history of incurring losses and the uncertainty of achieving profitability, reliance on research collaborations and strategic alliances, competition, patent infringement claims against CuraGen's products, processes and technologies, CuraGen's ability to protect its patents and proprietary rights and uncertainties relating to commercialization
'/>"/>

SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CuraGen Presents Update on Clinical Development Program for Belinostat
2. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
3. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
4. Malvern initiates European user group meetings for chemical imaging
5. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
6. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
7. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015  Mail-service and specialty ... consumers, employers and government health plans $11.8 billion ... by the Pharmaceutical Care Management Association (PCMA). ... offers one of the easiest ways to reduce ... Mark Merritt . "Policymakers should resist efforts to ...
(Date:3/4/2015)... 2015 From March 8-11, 2015 Excellis ... Management Conference and Expo in Orlando, ... supply chain education event, attended by nearly 500 ... the pharmaceutical distribution industry moving. Attracting thought-provoking speakers, ... issues important to healthcare distribution and technology, logistics ...
(Date:3/4/2015)... , March 4, 2015  Kannalife Sciences, Inc. ... has joined its Scientific Advisory Board to assist the ... efforts towards the use of cannabinoid therapeutics for the ... the forensic pathologist responsible for conducting the full autopsy ... of Fame center for the Pittsburgh Steelers. It was ...
Breaking Medicine Technology:PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Illinois Employers, Consumers and Public Programs by $11.8 Billion 2Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 2Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 3
(Date:3/5/2015)... March 05, 2015 Affirmed Housing is ... Cielo Carmel on March 4 at 10AM. The ... Sherri Lightner, Council president, City of San Diego; ... Atherton, Senior Vice President, Southern California Community Development, Bank ... CEO, San Diego Housing Commission. , Designed ...
(Date:3/5/2015)... March 05, 2015 Hoggan ... dynamometers, ergoFET physical therapy, ergonomic force gauges, ... for ergonomics, engineering, and research applications, introduced ... Dynamometer, available at http://www.HogganHealth.net . The ... offer healthcare professionals a handgrip muscle strength ...
(Date:3/5/2015)... 2015 Medical professionals suggest the physician ... a crisis that is worsening. The demand for doctors ... stay on top of the physician shortage, health care ... meet face-to-face with physicians and advanced practitioners throughout the ... Fair series. , Physician openings take an average of ...
(Date:3/4/2015)... Las Vegas, NV (PRWEB) March 04, 2015 ... good as the fight that is the main event. For ... announced and that fight will be for the UFC Featherweight ... against the brash, often out-spoken native of Ireland, Conor “Notorious” ... the MGM Grand Garden Arena in Las Vegas, NV. , ...
(Date:3/4/2015)... March 04, 2015 The federal litigation ... the statin drug caused patients to develop Type 2 ... Court, District of South Carolina. According to court documents, ... March 26, 2015 at 10:00 a.m. In advance of ... a Joint Status report to the Court by March ...
Breaking Medicine News(10 mins):Health News:SD City Council President Sherri Lightner and Affirmed Housing Break Ground on Affordable Homes in Carmel Valley 2Health News:New Handgrip Strength Tester Receives Rave Reviews At Physical Therapy Conference 2Health News:Physician Shortage Crisis Worsening 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 2Health News:Cheap UFC 189 Tickets: Jose Aldo vs. Conor McGregor UFC 189 Ticket Prices Slashed by Ticket Down for Featherweight Title 3Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3
... the 89th General Session & Exhibition of the International ... 40th Annual Meeting of the American Association for Dental ... Association for Dental Research, lead researcher F. Cheni will ... "Biodegradable Tooth-binding Micelles Inhibit Streptococcus mutans ( ...
... -- Girls in early adolescence who form friendships with boys ... a new research. The study included 400 female and ... interviewed annually over seven years about their friendship network and ... girls tend to limit their friendships to same-sex peers. But ...
... The oldest segment of Japan,s population will likely be the ... subsequent tsunami, based on data from previous catastrophic events. Approximately ... above. "Japan,s population with the highest proportion of ... of where the world as a whole is headed," said ...
... News) -- Scientists who,ve uncovered the chemistry of mosquito sex ... such as West Nile virus and dengue fever. The ... the male sperm of Aedes aegypti mosquitoes -- ... alter female mosquitoes, tendencies to feed, produce eggs and mate. ...
... passage of the Family Smoking Prevention and Tobacco Control ... (FDA) has met the ambitious implementation deadlines set forth ... congressional briefing hosted by the American Association for Cancer ... FDA Center for Tobacco Products, reviewed the many important ...
... is delivering on its commitment to help the world,s ... an affordable, reliable, and stable treatment for malaria that ... and children in Africa. The Honourable Gary Goodyear, Minister ... Brad Trost, Member of Parliament for SaskatoonHumboldt, announced the ...
Cached Medicine News:Health News:Biodegradable tooth-binding micelles inhibit Streptococcus mutans biofilm growth 2Health News:Teen Girls Who Befriend Boys at Higher Risk for Substance Abuse 2Health News:Japanese tsunami underscores need for elder disaster preparedness 2Health News:Center director says FDA hitting milestones in tobacco law 2Health News:Government of Canada announces results in fight to save women and children with malaria 2
... revolutionary product will provide you with ... of electroretinogram, visual evoked potential, or ... will allow you to perform ERGs ... double flash, photopic negative response, and ...
... The LABOTECH is an ... fully automating immunoenzymatic microplate techniques. ... system adaptable to many manufacturers' ... alternative to traditional R.I.A. and ...
The Rapidpoint 400/405 instrument is a point-of-care blood gas analyzer that's fast, easy to operate and reliable....
... diagnostic accuracy for appropriate treatment options , ... used to inject fluid into the intervertebral ... will measure the pressure of the fluid ... The physician can control the pressure of ...
Medicine Products: